Find clinical trials for Diabetes in St Louis, MO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus

Diabetes Mellitus

Obesity

Type 1 Diabetes Mellitus

Diabetic Foot

Overweight

Foot Ulcer

Diabetes trials near St Louis, MO, USA:

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease (SUGARNSALT)

inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...

Enrolling

Diabetic Nephropathies

Diabetes Mellitus Type 1

Drug: Placebo

Drug: Sotagliflozin

Phase 3

Alessandro Doria

St Louis, Missouri, United States and 17 other locations

A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes (SURPASS-EARLY)

This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...

Active, not recruiting

Type 2 Diabetes

Drug: Antihyperglycemic medication

Drug: Tirzepatide

Phase 4

Lilly

City of Saint Peters, Missouri, United States and 89 other locations

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT/rilparencel injections given 12 weeks (-14 day...

Enrolling

Type 2 Diabetes Mellitus

Chronic Kidney Diseases

Procedure: Sham Comparator

Biological: Renal Autologous Cell Therapy (REACT)

Phase 3

Prokidney

St Louis, Missouri, United States and 87 other locations

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes (DIAGNODE-3)

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Active, not recruiting

Type 1 Diabetes Mellitus

Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®

Biological: Placebo

Phase 3

Diamyd Medical

St Louis, Missouri, United States and 59 other locations

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple a...

Enrolling

Type 1 Diabetes Patients

Type 1 Diabetes Mellitus

Drug: CNP-103

Drug: Placebo

Phase 1, Phase 2

COUR Pharmaceuticals

St Louis, Missouri, United States and 28 other locations

Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting

Diabetic Cardiomyopathies

Drug: AT-001

Drug: Placebo

Phase 3

Applied Therapeutics

Saint Louis, Missouri, United States and 78 other locations

A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy

This study will look at the effects of CagriSema in people with both type 2 diabetes and painful diabetic peripheral neuropathy, co...

Active, not recruiting

Diabetes Mellitus, Type 2

Diabetic Peripheral Neuropathy

Drug: CagriSema (Cagrilintide B and Semaglutide I)

Drug: Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)

Phase 2

Novo Nordisk

St Louis, Missouri, United States and 54 other locations

A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes (FOCUS)

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting

Diabetes Mellitus, Type 2

Drug: Semaglutide

Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk

Chesterfield, Missouri, United States and 228 other locations

Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers (Mavericks)

the treatment with the COMS One device in subjects with refractory diabetic foot ulcers (DFUs). The prospective randomized, double-blinded, ...

Enrolling

Diabetic Foot Ulcer

Device: COMS One device

Device: Sham device

Piomic Medical

O'Fallon, Illinois, United States and 25 other locations

A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm (PAVILION)

Study GR41675 is a Multicenter, Randomized Study in Participants with Diabetic Retinopathy (DR) Without Center-Involved Diabetic Ma...

Active, not recruiting

Diabetic Retinopathy

Drug: PDS Implant Pre-Filled with 100 mg/mL Ranibizumab

Drug: Intravitreal Ranibizumab 0.5 mg Injection

Phase 3

Roche

Chesterfield, Missouri, United States and 75 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Diabetes in .css-epvm6{white-space:nowrap;}St Louis, MO

Related conditions:

Diabetes trials near St Louis, MO, USA:

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease (SUGARNSALT)

A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes (SURPASS-EARLY)

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes (DIAGNODE-3)

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy

A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy

A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes (FOCUS)

Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers (Mavericks)

A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm (PAVILION)

Find clinical trials for Diabetes in St Louis, MO